Zhu L - Search Results

1

Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer.

Miao Y, Konno Y, Wang B, Zhu L, Zhai T, Ihira K, Kobayashi N, Watari H, Jin X, Yue J, Dong P, Fang M. Miao Y, et al. Among authors: zhu l. J Transl Med. 2023 Feb 25;21(1):151. doi: 10.1186/s12967-023-03998-8. J Transl Med. 2023. PMID: 36829176 Free PMC article.

2

KDM3B-ETF1 fusion gene downregulates LMO2 via the WNT/β-catenin signaling pathway, promoting metastasis of invasive ductal carcinoma.

Hu A, Hong F, Li D, Xie Q, Chen K, Zhu L, He H. Hu A, et al. Among authors: zhu l. Cancer Gene Ther. 2022 Feb;29(2):215-224. doi: 10.1038/s41417-021-00301-z. Epub 2021 Apr 7. Cancer Gene Ther. 2022. PMID: 33828234

3

Metformin as anticancer agent and adjuvant in cancer combination therapy: Current progress and future prospect.

Zhu L, Yang K, Ren Z, Yin D, Zhou Y. Zhu L, et al. Transl Oncol. 2024 Jun;44:101945. doi: 10.1016/j.tranon.2024.101945. Epub 2024 Mar 30. Transl Oncol. 2024. PMID: 38555742 Free PMC article. Review.

4

Praja2 suppresses the growth of gastric cancer by ubiquitylation of KSR1 and inhibiting MEK-ERK signal pathways.

Zhao Z, Zhu L, Xing Y, Zhang Z. Zhao Z, et al. Among authors: zhu l. Aging (Albany NY). 2021 Jan 10;13(3):3886-3897. doi: 10.18632/aging.202356. Epub 2021 Jan 10. Aging (Albany NY). 2021. PMID: 33461174 Free PMC article.

5

lncRNA NEAT1 promotes the Taxol resistance of breast cancer via sponging the miR-23a-3p-FOXA1 axis.

Zhu L, Wang F, Fan W, Jin Z, Teng C, Zhang J. Zhu L, et al. Acta Biochim Biophys Sin (Shanghai). 2021 Aug 31;53(9):1198-1206. doi: 10.1093/abbs/gmab098. Acta Biochim Biophys Sin (Shanghai). 2021. PMID: 34327529 Free article.

6

Curcumin Synergizes with Cisplatin to Inhibit Colon Cancer through Targeting the MicroRNA-137-Glutaminase Axis.

Fan WH, Wang FC, Jin Z, Zhu L, Zhang JX. Fan WH, et al. Among authors: zhu l. Curr Med Sci. 2022 Feb;42(1):108-117. doi: 10.1007/s11596-021-2469-0. Epub 2021 Dec 26. Curr Med Sci. 2022. PMID: 34958454

7

Elevated miR-23a impairs trophoblast migration and invasiveness through HDAC2 inhibition and NF-κB activation.

Fan Y, Dong Z, Zhou G, Fu J, Zhan L, Gao M, Zhu L, Zhang Y. Fan Y, et al. Among authors: zhu l. Life Sci. 2020 Nov 15;261:118358. doi: 10.1016/j.lfs.2020.118358. Epub 2020 Aug 28. Life Sci. 2020. PMID: 32866518

8

Downregulation of miR-337-3p in hypoxia/reoxygenation neuroblastoma cells increases KCTD11 expression.

Zhu L, Xin YJ, He M, Bian J, Cheng XL, Li R, Li JJ, Wang J, Liu JY, Yang L. Zhu L, et al. J Biochem Mol Toxicol. 2024 Apr;38(4):e23685. doi: 10.1002/jbt.23685. J Biochem Mol Toxicol. 2024. PMID: 38495002

9

Hypoxia-induced miR-9 expression promotes ovarian cancer progression via activating PI3K/AKT/mTOR/GSK3β signaling pathway.

Zhu WJ, Huang HH, Feng YF, Zhan L, Yang J, Zhu L, Wang QY, Wei B, Wang WY. Zhu WJ, et al. Among authors: zhu l. Neoplasma. 2023 Apr;70(2):216-228. doi: 10.4149/neo_2023_221103N1079. Epub 2023 Mar 24. Neoplasma. 2023. PMID: 36964721

10

DCLRE1B promotes tumor progression and predicts immunotherapy response through METTL3-mediated m6A modification in pancreatic cancer.

Li L, Wang F, Deng Z, Zhang G, Zhu L, Zhao Z, Liu R. Li L, et al. Among authors: zhu l. BMC Cancer. 2023 Nov 7;23(1):1073. doi: 10.1186/s12885-023-11524-8. BMC Cancer. 2023. PMID: 37936074 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,900 results

Search Page

Filters